N | |
---|---|
Age group (yrs) | |
19–30 | 7 |
31–40 | 3 |
41–50 | 4 |
51–60 | 0 |
> 60 | 5 |
Height (cm) | |
< 115 | 5 |
115–130 | 10 |
> 130 | 4 |
Reproductive health | |
Menarche (median, yrs) | 12.5 |
Cycle length (variation, median, days) | 21–60, 28 |
Menstrual flow | |
sparse | 2 |
normal | 15 |
heavy | 2 |
Pregnancies | 6/19 |
Births | |
0 | 14 |
1–2 | 1 |
> 2 | 4 |
Current hormonal therapy | 5/19 |
Combined contraception pills | 1 |
Progestin only -pills | 2 |
Hormone replacement therapy | 2 |
Immunodeficiency | |
Suseptibility to infectionsa | |
Yes | 9 |
Intermediate | 4 |
Normal | 6 |
Previous skin warts | |
Yes | 4 |
No | 14 |
Repeated genital infections | 6/19 |
Previous malignancyb | 3 |
Leucocytes (× 109/L) (range, median) | 3.2–13.4; 5.6 |
Lymphocytes (× 109/L) (range, median) | 0.5–2.58; 1.22 |
Neutrophiles (× 109/L) (range, median) | 1.74–10.65; 3.37 |